FDA Submits Proposed Collection of Information for OMB Review

Summary

The Food and Drug Administration (FDA) is announcing that a proposed collection of information has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995, in response to a request for comment on user fees associated with animal drugs and generic drugs.